Literature DB >> 19808471

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.

Paul Dorian1, Peter G Guerra, Charles R Kerr, Suzan S O'Donnell, Eugene Crystal, Anne M Gillis, L Brent Mitchell, Denis Roy, Allan C Skanes, M Sarah Rose, D George Wyse.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is commonly associated with impaired quality of life. There is no simple validated scale to quantify the functional illness burden of AF. The Canadian Cardiovascular Society Severity in Atrial Fibrillation (CCS-SAF) scale is a bedside scale that ranges from class 0 to 4, from no effect on functional quality of life to a severe effect on life quality. This study was performed to validate the scale. METHODS AND
RESULTS: In 484 patients with documented AF (62.2+/-12.5 years of age, 67% men; 62% paroxysmal and 38% persistent/permanent), the SAF class was assessed and 2 validated quality-of-life questionnaires were administered: the SF-36 generic scale and the disease-specific AFSS (University of Toronto Atrial Fibrillation Severity Scale). There is a significant linear graded correlation between the SAF class and measures of symptom severity, physical and emotional components of quality of life, general well-being, and health care consumption related to AF. Patients with SAF class 0 had age- and sex-standardized SF-36 scores of 0.15+/-0.16 and -0.04+/-0.31 (SD units), that is, units away from the mean population score for the mental and physical summary scores, respectively. For each unit increase in SAF class, there is a 0.36 and 0.40 SD unit decrease in the SF-36 score for the physical and mental components. As the SAF class increases from 0 to 4, the symptom severity score (range, 0 to 35) increases from 4.2+/-5.0 to 18.4+/-7.8 (P<0.0001).
CONCLUSIONS: The CCS-SAF scale is a simple semiquantitative scale that closely approximates patient-reported subjective measures of quality of life in AF and may be practical for clinical use.

Entities:  

Mesh:

Year:  2009        PMID: 19808471     DOI: 10.1161/CIRCEP.108.812347

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  38 in total

Review 1.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

2.  Global collaboration needed for AF.

Authors:  Valentin Fuster; Bryony M Mearns
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

Review 3.  Tackling Patient-Reported Outcomes in Atrial Fibrillation and Heart Failure: Identifying Disease-Specific Symptoms?

Authors:  Benjamin A Steinberg; Jonathan P Piccini
Journal:  Cardiol Clin       Date:  2019-05       Impact factor: 2.213

Review 4.  Health-related quality of life questionnaires: an important method to evaluate patient outcomes in atrial fibrillation ablation.

Authors:  Andrew C T Ha; Paul Dorian
Journal:  J Interv Card Electrophysiol       Date:  2012-10-10       Impact factor: 1.900

5.  Combined Catheter Ablation for Atrial Fibrillation and Watchman® Left Atrial Appendage Occlusion Procedures: A Single Centre Experience.

Authors:  Daniel T Walker; Julie A Humphries; Karen P Phillips
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 6.  The Impact of Atrial Fibrillation Ablation on Quality of Life.

Authors:  Jacob Pontoppidan
Journal:  J Atr Fibrillation       Date:  2012-10-06

7.  Symptom challenges after atrial fibrillation ablation.

Authors:  Kathryn A Wood; Angel H Barnes; Sudeshna Paul; Kristina A Hines; Kevin P Jackson
Journal:  Heart Lung       Date:  2017-09-18       Impact factor: 2.210

Review 8.  Challenges in the classification of atrial fibrillation.

Authors:  Steven A Lubitz; Emelia J Benjamin; Jeremy N Ruskin; Valentin Fuster; Patrick T Ellinor
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

9.  Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation.

Authors:  Khang-Li Looi; Parag Gajendragadkar; Tamer Taha; Maros Elsik; Elizabeth Scully; Patrick Heck; Simon Fynn; Munmohan Virdee; David Begley
Journal:  J Interv Card Electrophysiol       Date:  2012-10-25       Impact factor: 1.900

Review 10.  A contemporary review on the genetic basis of atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.